Newave Pharmaceutical Inc
4 clinical trials · Sponsor
◉ Watch Newave Pharmaceutical Inc
| Record | Firm | Date |
|---|---|---|
| ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL (NCT07342478) | Newave Pharmaceutical Inc | 2026-04-23 |
| Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. (NCT04771572) | Newave Pharmaceutical Inc | 2022-05-08 |
| Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies. (NCT04775745) | Newave Pharmaceutical Inc | 2021-07-19 |
| Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML (NCT04139434) | Newave Pharmaceutical Inc | 2020-07-06 |
Track Newave Pharmaceutical Inc automatically
Every clearance here is in the API, with alerts when new ones post.